Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous foaters

ABSTRACT Purpose: This study aimed to evaluate the long-term safety and efficacy of neodymium-doped yttrium aluminum garnet (Nd:YAG) vitreolysis for symptomatic vitreous floaters as it remains a controversial procedure due to insufficient robust evidence in the literature for the maintenance of the results and absence of adverse effects. Methods: This is an observational extension to the previously presented prospective, randomized, double-blind clinical trial. Eight of thirteen subjects who underwent vitreolysis with YAG laser returned for a late reevaluation, 18 months after the procedure, to evaluate the efficacy and safety of the procedure. Results: All patients maintained the improvement in symptomatology noted after the procedure, with 25% showing complete improvement and a similar proportion (37.5%) reporting significant or partial improvement. Objective improvement in opacity was similar to that found at 6 months follow-up. The NEI-VFQ 25 quality of life questionnaire showed no statistically significant difference in responses between the 6th and 18th month. No adverse effects were noted on clinical examination or reported by patients. Conclusion: Vitreolysis efficacy observed at 6 months of follow-up was maintained until the eighteenth month, with all patients reporting improvement from the pre-procedure state. No late adverse effects were noted. A larger randomized clinical trial is needed to confirm the safety of the procedure.

Saved in:
Bibliographic Details
Main Authors: Nunes,Guilherme M., Ludwig,Gustavo D., Gemelli,Henrique, Zanotele,Márgara, Serracarbassa,Pedro D.
Format: Digital revista
Language:English
Published: Conselho Brasileiro de Oftalmologia 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492022005010216
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-27492022005010216
record_format ojs
spelling oai:scielo:S0004-274920220050102162022-09-19Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous foatersNunes,Guilherme M.Ludwig,Gustavo D.Gemelli,HenriqueZanotele,MárgaraSerracarbassa,Pedro D. Laser therapy Lasers, solid-state Vitrectomy Vitreous body Vitreoretinal surgery Visual acuity Eye diseases Quality of life Surveys and questionnaires ABSTRACT Purpose: This study aimed to evaluate the long-term safety and efficacy of neodymium-doped yttrium aluminum garnet (Nd:YAG) vitreolysis for symptomatic vitreous floaters as it remains a controversial procedure due to insufficient robust evidence in the literature for the maintenance of the results and absence of adverse effects. Methods: This is an observational extension to the previously presented prospective, randomized, double-blind clinical trial. Eight of thirteen subjects who underwent vitreolysis with YAG laser returned for a late reevaluation, 18 months after the procedure, to evaluate the efficacy and safety of the procedure. Results: All patients maintained the improvement in symptomatology noted after the procedure, with 25% showing complete improvement and a similar proportion (37.5%) reporting significant or partial improvement. Objective improvement in opacity was similar to that found at 6 months follow-up. The NEI-VFQ 25 quality of life questionnaire showed no statistically significant difference in responses between the 6th and 18th month. No adverse effects were noted on clinical examination or reported by patients. Conclusion: Vitreolysis efficacy observed at 6 months of follow-up was maintained until the eighteenth month, with all patients reporting improvement from the pre-procedure state. No late adverse effects were noted. A larger randomized clinical trial is needed to confirm the safety of the procedure.info:eu-repo/semantics/openAccessConselho Brasileiro de OftalmologiaArquivos Brasileiros de Oftalmologia n.ahead 20222022-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492022005010216en10.5935/0004-2749.2021-0395
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Nunes,Guilherme M.
Ludwig,Gustavo D.
Gemelli,Henrique
Zanotele,Márgara
Serracarbassa,Pedro D.
spellingShingle Nunes,Guilherme M.
Ludwig,Gustavo D.
Gemelli,Henrique
Zanotele,Márgara
Serracarbassa,Pedro D.
Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous foaters
author_facet Nunes,Guilherme M.
Ludwig,Gustavo D.
Gemelli,Henrique
Zanotele,Márgara
Serracarbassa,Pedro D.
author_sort Nunes,Guilherme M.
title Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous foaters
title_short Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous foaters
title_full Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous foaters
title_fullStr Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous foaters
title_full_unstemmed Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous foaters
title_sort long-term evaluation of the efficacy and safety of nd:yag laser vitreolysis for symptomatic vitreous foaters
description ABSTRACT Purpose: This study aimed to evaluate the long-term safety and efficacy of neodymium-doped yttrium aluminum garnet (Nd:YAG) vitreolysis for symptomatic vitreous floaters as it remains a controversial procedure due to insufficient robust evidence in the literature for the maintenance of the results and absence of adverse effects. Methods: This is an observational extension to the previously presented prospective, randomized, double-blind clinical trial. Eight of thirteen subjects who underwent vitreolysis with YAG laser returned for a late reevaluation, 18 months after the procedure, to evaluate the efficacy and safety of the procedure. Results: All patients maintained the improvement in symptomatology noted after the procedure, with 25% showing complete improvement and a similar proportion (37.5%) reporting significant or partial improvement. Objective improvement in opacity was similar to that found at 6 months follow-up. The NEI-VFQ 25 quality of life questionnaire showed no statistically significant difference in responses between the 6th and 18th month. No adverse effects were noted on clinical examination or reported by patients. Conclusion: Vitreolysis efficacy observed at 6 months of follow-up was maintained until the eighteenth month, with all patients reporting improvement from the pre-procedure state. No late adverse effects were noted. A larger randomized clinical trial is needed to confirm the safety of the procedure.
publisher Conselho Brasileiro de Oftalmologia
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492022005010216
work_keys_str_mv AT nunesguilhermem longtermevaluationoftheefficacyandsafetyofndyaglaservitreolysisforsymptomaticvitreousfoaters
AT ludwiggustavod longtermevaluationoftheefficacyandsafetyofndyaglaservitreolysisforsymptomaticvitreousfoaters
AT gemellihenrique longtermevaluationoftheefficacyandsafetyofndyaglaservitreolysisforsymptomaticvitreousfoaters
AT zanotelemargara longtermevaluationoftheefficacyandsafetyofndyaglaservitreolysisforsymptomaticvitreousfoaters
AT serracarbassapedrod longtermevaluationoftheefficacyandsafetyofndyaglaservitreolysisforsymptomaticvitreousfoaters
_version_ 1756373381715853312